Rallis India skid 5.70% to Rs 277.85 after the company's consolidated net profit fell 13.3% to Rs 39.56 crore on a 10.1% increase in net sales to Rs 628.08 crore in Q3 FY22 over Q3 FY21.
Consolidated profit before tax (PBT) skid 14.5% to Rs 53.07 crore in Q3 FY22 from Rs 62.05 crore in Q3 FY21. Rallis India, in its press release, stated that the raw material availability and costs continued to be challenge during the quarter. The Ankleshwar debottlenecking project for two key active ingredients were completed and commissioned. The MPP project has been progressing well. The formulation plant at Dahej, CZ - Phase 1 was completed while the commercial production was started.
Meanwhile, Rallis India launched new microbial biopesticide, a potash rich organic manure and a new maize hybrid. The focus continued on supply chain amidst availability and logistic challenges and high international freight rates. The select commodity prices and export demand for crop protection were good. The overall Rabi sown area in India remained stable.
Sanjiv Lal, the managing director (MD) and chief executive officer (CEO) of Rallis India, said, "The erratic monsoon season this year has not favoured agri input companies as excessive rainfall continued into Q3 in the southern states. Despite these challenges, our domestic crop care business grew at 9.4%, and exports by 19% during the quarter. The seeds industry continued to face headwinds due to restrictions for sale of paddy and maize hybrids in some states. Supply chain challenges continued into Q3 with availability being a challenge for certain intermediates as well as steep inflation in prices. We are focussed on minimising the disruptions to our production as much as possible and calibrated price corrections have helped in partially neutralizing the RM cost inflation."
"On a longer term basis, our capex plans, new product introduction plans and demand generation investments remain on course as we do believe that normalcy will be restored progressively. While positioning ourselves so, we are also consistently prioritising the safety and well-being of all our employees and other stakeholders."
Rallis India is a subsidiary of Tata Chemicals and a part of Tata Group. It is one of India's leading agro sciences companies.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
